
|Videos|December 9, 2021
The Pharmacology and Pharmacokinetics of Cabotegravir and Rilpivirine
In this video, Dr. Sherman describes the pharmacology and pharmacokinetics of cabotegravir and rilpivirine as long acting injectable antiretroviral therapy agents.
Advertisement
Pharmacy Times spoke with Dr. Elizabeth Sherman, PharmD, about her session at the ASHP Midyear 2021 conference, titled "Long Acting Antiretroviral Therapy for the Treatment and Prevention of HIV Infection”.
In this video, Dr. Sherman describes the pharmacology and pharmacokinetics of cabotegravir and rilpivirine as long acting injectable antiretroviral therapy agents.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tradipitant Becomes First Treatment Approved for Vomiting Due to Motion Sickness in 4 Decades
2
Aspirin Dosage and Decision-Making: What Pharmacists Should Know
3
FDA May Relax Dietary Supplement Warning Label Rules: Implications for Public Health
4
New Drug Approach Targets KRAS-Mutant Lung Cancer to Overcome Therapy Resistance
5












































































































































































































